Associated Papers
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade.
Chaib M et al.
Biorxiv : the Preprint Server for Biology, 2025
Setdb1 Loss Induces Type I Interferons and Immune Clearance of Melanoma.
McGeary MK et al.
Cancer Immunology Research, 2025
Age-associated modulation of TREM1/2- expressing macrophages promotes melanoma progression and metastasis.
Scortegagna M et al.
Biorxiv : the Preprint Server for Biology, 2024
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma.
Zimmerman SM et al.
Cancer Immunology, Immunotherapy : Cii, 2024
Stat3-mediated Atg7 expression enhances anti-tumor immunity in melanoma.
Zimmerman SM et al.
Biorxiv : the Preprint Server for Biology, 2024
Setdb1 -loss induces type-I interferons and immune clearance of melanoma.
McGeary MK et al.
Biorxiv : the Preprint Server for Biology, 2023
5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING.
Tian J et al.
The Embo Journal, 2021
Autophagy maintains tumour growth through circulating arginine.
Poillet-Perez L et al.
Nature, 2018
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Manguso RT et al.
Nature, 2017
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
Berres ML et al.
The Journal of Experimental Medicine, 2014
Select a paper to view details